Venture capital investors are keeping a close eye on the FDA, especially since the way it approves medical devices may be changing. Not only are they watching, they are involved in pushing for reforms. The Medical Innovation and Competitiveness Coalition (MedIC) is one of two organizations along with the Medical Device Venture Council (MDVC) which says, according to this Wall Street Journal article, a “risk-averse culture at the FDA that has been stifling innovation and driving jobs overseas.”
Read the rest of the article here.